FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915676497> ?p ?o ?g. }

• W2915676497 endingPage "550" @default.
• W2915676497 startingPage "542" @default.
• W2915676497 abstract "Ibrutinib therapy is safe and effective in patients with chronic lymphocytic leukemia (CLL). Currently, ibrutinib is administered continuously until disease progression. Combination regimens with ibrutinib are being developed to deepen response which could allow for ibrutinib maintenance (IM) discontinuation. Among untreated older patients with CLL, clinical investigators had the following questions: (i) does ibrutinib + venetoclax + obinutuzumab (IVO) with IM have superior progression-free survival (PFS) compared with ibrutinib + obinutuzumab (IO) with IM, and (ii) does the treatment strategy of IVO + IM for patients without minimal residual disease complete response (MRD- CR) or IVO + IM discontinuation for patients with MRD- CR have superior PFS compared with IO + IM.Conventional designs randomize patients to IO with IM or IVO with IM to address the first objective, or randomize patients to each treatment strategy to address the second objective. A sequential multiple assignment randomized trial (SMART) design and analysis is proposed to address both objectives.A SMART design strategy is appropriate when comparing adaptive interventions, which are defined by an individual's sequence of treatment decisions and guided by intermediate outcomes, such as response to therapy. A review of common applications of SMART design strategies is provided. Specific to the SMART design previously considered for Alliance study A041702, the general structure of the SMART is presented, an approach to sample size and power calculations when comparing adaptive interventions embedded in the SMART with a time-to-event end point is fully described, and analyses plans are outlined.SMART design strategies can be used in cancer clinical trials with adaptive interventions to identify optimal treatment strategies. Further, standard software exists to provide sample size, power calculations, and data analysis for a SMART design." @default.
• W2915676497 created "2019-03-02" @default.
• W2915676497 creator A5000921376 @default.
• W2915676497 creator A5002528975 @default.
• W2915676497 creator A5006102391 @default.
• W2915676497 creator A5014241029 @default.
• W2915676497 creator A5019260167 @default.
• W2915676497 creator A5057991167 @default.
• W2915676497 creator A5060302112 @default.
• W2915676497 date "2019-04-01" @default.
• W2915676497 modified "2023-10-16" @default.
• W2915676497 title "Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia" @default.
• W2915676497 cites W1783402133 @default.
• W2915676497 cites W1991676478 @default.
• W2915676497 cites W1995001963 @default.
• W2915676497 cites W2007151269 @default.
• W2915676497 cites W2027795129 @default.
• W2915676497 cites W2028045726 @default.
• W2915676497 cites W2032303836 @default.
• W2915676497 cites W2071549499 @default.
• W2915676497 cites W2075875145 @default.
• W2915676497 cites W2098101547 @default.
• W2915676497 cites W2118703246 @default.
• W2915676497 cites W2136887049 @default.
• W2915676497 cites W2142099365 @default.
• W2915676497 cites W2142437885 @default.
• W2915676497 cites W2144223323 @default.
• W2915676497 cites W2146740605 @default.
• W2915676497 cites W2147800896 @default.
• W2915676497 cites W2149360785 @default.
• W2915676497 cites W2153923291 @default.
• W2915676497 cites W2156682402 @default.
• W2915676497 cites W2162512884 @default.
• W2915676497 cites W2167371237 @default.
• W2915676497 cites W2192121806 @default.
• W2915676497 cites W2233614027 @default.
• W2915676497 cites W2327522594 @default.
• W2915676497 cites W2339692928 @default.
• W2915676497 cites W2787863642 @default.
• W2915676497 cites W2792666902 @default.
• W2915676497 cites W2902484351 @default.
• W2915676497 cites W2902706178 @default.
• W2915676497 cites W4293241248 @default.
• W2915676497 doi "https://doi.org/10.1093/annonc/mdz053" @default.
• W2915676497 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6735877" @default.
• W2915676497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30799502" @default.
• W2915676497 hasPublicationYear "2019" @default.
• W2915676497 type Work @default.
• W2915676497 sameAs 2915676497 @default.
• W2915676497 citedByCount "7" @default.
• W2915676497 countsByYear W29156764972020 @default.
• W2915676497 countsByYear W29156764972021 @default.
• W2915676497 countsByYear W29156764972023 @default.
• W2915676497 crossrefType "journal-article" @default.
• W2915676497 hasAuthorship W2915676497A5000921376 @default.
• W2915676497 hasAuthorship W2915676497A5002528975 @default.
• W2915676497 hasAuthorship W2915676497A5006102391 @default.
• W2915676497 hasAuthorship W2915676497A5014241029 @default.
• W2915676497 hasAuthorship W2915676497A5019260167 @default.
• W2915676497 hasAuthorship W2915676497A5057991167 @default.
• W2915676497 hasAuthorship W2915676497A5060302112 @default.
• W2915676497 hasBestOaLocation W29156764971 @default.
• W2915676497 hasConcept C126322002 @default.
• W2915676497 hasConcept C143998085 @default.
• W2915676497 hasConcept C168563851 @default.
• W2915676497 hasConcept C2777607594 @default.
• W2915676497 hasConcept C2777938653 @default.
• W2915676497 hasConcept C2778461978 @default.
• W2915676497 hasConcept C2778715236 @default.
• W2915676497 hasConcept C2779675984 @default.
• W2915676497 hasConcept C2779878957 @default.
• W2915676497 hasConcept C535046627 @default.
• W2915676497 hasConcept C71924100 @default.
• W2915676497 hasConceptScore W2915676497C126322002 @default.
• W2915676497 hasConceptScore W2915676497C143998085 @default.
• W2915676497 hasConceptScore W2915676497C168563851 @default.
• W2915676497 hasConceptScore W2915676497C2777607594 @default.
• W2915676497 hasConceptScore W2915676497C2777938653 @default.
• W2915676497 hasConceptScore W2915676497C2778461978 @default.
• W2915676497 hasConceptScore W2915676497C2778715236 @default.
• W2915676497 hasConceptScore W2915676497C2779675984 @default.
• W2915676497 hasConceptScore W2915676497C2779878957 @default.
• W2915676497 hasConceptScore W2915676497C535046627 @default.
• W2915676497 hasConceptScore W2915676497C71924100 @default.
• W2915676497 hasFunder F4320337351 @default.
• W2915676497 hasIssue "4" @default.
• W2915676497 hasLocation W29156764971 @default.
• W2915676497 hasLocation W29156764972 @default.
• W2915676497 hasLocation W29156764973 @default.
• W2915676497 hasLocation W29156764974 @default.
• W2915676497 hasOpenAccess W2915676497 @default.
• W2915676497 hasPrimaryLocation W29156764971 @default.
• W2915676497 hasRelatedWork W1961905065 @default.
• W2915676497 hasRelatedWork W2106082064 @default.
• W2915676497 hasRelatedWork W2204827588 @default.
• W2915676497 hasRelatedWork W2558110451 @default.
• W2915676497 hasRelatedWork W2564505704 @default.
• W2915676497 hasRelatedWork W2735082830 @default.

• next